PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion

Journal of Cell Biology

Volumn 211, Issue 4, 2015, Pages 863-879

  Dart, Anna E ^a   Box, Gary M ^b   Court, William ^b   Gale, Madeline E ^a   Brown, John P ^c   Pinder, Sarah E ^c   Eccles, Suzanne A ^b   Wells, Claire M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN; CULLIN 5; P21 ACTIVATED KINASE 4; PAXILLIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; P21 ACTIVATED KINASE; PAK4 PROTEIN, HUMAN; PROTEIN CDC42; PXN PROTEIN, HUMAN; RHOU PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; CELL MOTION; ENZYME STABILITY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN DOMAIN; TUMOR CELL LINE;

CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME STABILITY; HUMANS; P21-ACTIVATED KINASES; PAXILLIN; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RHO GTP-BINDING PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84970959764     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201501072     Document Type: Article

References (63)

1. Abo, A., J. Qu, M.S. Cammarano, C. Dan, A. Fritsch, V. Baud, B. Belisle, and A. Minden. 1998. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J. 17:6527-6540. http://dx.doi.org/10.1093/emboj/17.22.6527
2. Ahmed, T., K. Shea, J.R. Masters, G.E. Jones, and C.M. Wells. 2008. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cell. Signal. 20:1320-1328. http://dx.doi.org/10.1016/j.cellsig.2008.02.021
3. Baskaran, Y., Y.W. Ng, W. Selamat, F.T. Ling, and E. Manser. 2012. Group I and II mammalian PAKs have different modes of activation by Cdc42. EMBO Rep. 13:653-659. http://dx.doi.org/10.1038/embor.2012.75
4. Bhavsar, P.J., E. Infante, A. Khwaja, and A.J. Ridley. 2013. Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration. Oncogene. 32:198-208. http://dx.doi.org/10.1038/onc.2012.42
5. Bompard, G., G. Rabeharivelo, M. Frank, J. Cau, C. Delsert, and N. Morin. 2010. Subgroup II PAK-mediated phosphorylation regulates Ran activity during mitosis. J. Cell Biol. 190:807-822. http://dx.doi.org/10.1083/jcb.200912056
6. Callow, M.G., F. Clairvoyant, S. Zhu, B. Schryver, D.B. Whyte, J.R. Bischoff, B. Jallal, and T. Smeal. 2002. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J. Biol. Chem. 277:550-558. http://dx.doi.org/10.1074/jbc.M105732200
7. Chuang, Y.Y., A. Valster, S.J. Coniglio, J.M. Backer, and M. Symons. 2007. The atypical Rho family GTPase Wrch-1 regulates focal adhesion formation and cell migration. J. Cell Sci. 120:1927-1934. http://dx.doi.org/10.1242/jcs.03456
8. Dart, A.E., and C.M. Wells. 2013. P21-activated kinase 4-not just one of the PAK. Eur. J. Cell Biol. 92:129-138. http://dx.doi.org/10.1016/j.ejcb.2013.03.002
9. de la Vega, M., J.F. Burrows, and J.A. Johnston. 2011. Ubiquitination: Added complexity in Ras and Rho family GTPase function. Small GTPases. 2:192-201. http://dx.doi.org/10.4161/sgtp.2.4.16707
10. Dickover, M., J.M. Hegarty, K. Ly, D. Lopez, H. Yang, R. Zhang, N. Tedeschi, T.K. Hsiai, and N.C. Chi. 2014. The atypical Rho GTPase, RhoU, regulates cell-adhesion molecules during cardiac morphogenesis. Dev. Biol. 389:182-191. http://dx.doi.org/10.1016/j.ydbio.2014.02.014
11. Dong, J.M., L.S. Lau, Y.W. Ng, L. Lim, and E. Manser. 2009. Paxillin nuclear-cytoplasmic localization is regulated by phosphorylation of the LD4 motif: evidence that nuclear paxillin promotes cell proliferation. Biochem. J. 418:173-184. http://dx.doi.org/10.1042/BJ20080170
12. Eswaran, J., M. Soundararajan, R. Kumar, and S. Knapp. 2008. UnPAKing the class differences among p21-activated kinases. Trends Biochem. Sci. 33:394-403. http://dx.doi.org/10.1016/j.tibs.2008.06.002
13. Fay, M.J., K.A. Longo, G.A. Karathanasis, D.M. Shope, C.J. Mandernach, J.R. Leong, A. Hicks, K. Pherson, and A. Husain. 2003. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol. Cancer. 2:40. http://dx.doi.org/10.1186/1476-4598-2-40
14. Garcia, R., R.A. Franklin, and J.A. McCubrey. 2006. EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells. Cell Cycle. 5:2820-2826. http://dx.doi.org/10.4161/cc.5.23.3535
15. Gnesutta, N., J. Qu, and A. Minden. 2001. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276:14414-14419
16. Ha, B.H., M.J. Davis, C. Chen, H.J. Lou, J. Gao, R. Zhang, M. Krauthammer, R. Halaban, J. Schlessinger, B.E. Turk, and T.J. Boggon. 2012. Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate. Proc. Natl. Acad. Sci. USA. 109:16107-16112. http://dx.doi.org/10.1073/pnas.1214447109
17. Jean, S., and A.A. Kiger. 2012. Coordination between RAB GTPase and phosphoinositide regulation and functions. Nat. Rev. Mol. Cell Biol. 13:463-470. http://dx.doi.org/10.1038/nrm3379
18. Kessler, B.M. 2013. Ubiquitin- omics reveals novel networks and associations with human disease. Curr. Opin. Chem. Biol. 17:59-65. http://dx.doi.org/10.1016/j.cbpa.2012.12.024
19. Kile, B.T., B.A. Schulman, W.S. Alexander, N.A. Nicola, H.M. Martin, and D.J. Hilton. 2002. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27:235-241. http://dx.doi.org/10.1016/S0968-0004(02)02085-6
20. Kirikoshi, H., H. Sekihara, and M. Katoh. 2001. WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells. Biochem. Biophys. Res. Commun. 283:798-805. http://dx.doi.org/10.1006/bbrc.2001.4855
21. Lee, R.H., H. Iioka, M. Ohashi, S. Iemura, T. Natsume, and N. Kinoshita. 2007. XRab40 and XCullin5 form a ubiquitin ligase complex essential for the noncanonical Wnt pathway. EMBO J. 26:3592-3606. http://dx.doi.org/10.1038/sj.emboj.7601781
22. Li, X., and A. Minden. 2005. PAK4 functions in tumor necrosis factor (TNF)α-induced survival pathways by facilitating TRA DD binding to the TNF receptor. J. Biol. Chem. 280:41192-41200. http://dx.doi.org/10.1074/jbc.M506884200
23. Li, Y., Y. Shao, Y. Tong, T. Shen, J. Zhang, Y. Li, H. Gu, and F. Li. 2012. Nucleo-cytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling. Biochim. Biophys. Acta. 1823:465-475. http://dx.doi.org/10.1016/j.bbamcr.2011.11.013
24. Liu, Y., H. Xiao, Y. Tian, T. Nekrasova, X. Hao, H.J. Lee, N. Suh, C.S. Yang, and A. Minden. 2008. The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol. Cancer Res. 6:1215-1224. http://dx.doi.org/10.1158/1541-7786.MCR-08-0087
25. Liu, Y., N. Chen, X. Cui, X. Zheng, L. Deng, S. Price, V. Karantza, and A. Minden. 2010. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene. 29:5883-5894. http://dx.doi.org/10.1038/onc.2010.329
26. Murray, B.W., C. Guo, J. Piraino, J.K. Westwick, C. Zhang, J. Lamerdin, E. Dagostino, D. Knighton, C.M. Loi, M. Zager, et al. 2010. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc. Natl. Acad. Sci. USA. 107:9446-9451. http://dx.doi.org/10.1073/pnas.0911863107
27. Nayal, A., D.J. Webb, C.M. Brown, E.M. Schaefer, M. Vicente-Manzanares, and A.R. Horwitz. 2006. Paxillin phosphorylation at Ser273 localizes a GIT1-PIX-PAK complex and regulates adhesion and protrusion dynamics. J. Cell Biol. 173:587-589. http://dx.doi.org/10.1083/jcb.200509075
28. Nethe, M., and P.L. Hordijk. 2010. The role of ubiquitylation and degradation in RhoGTPase signalling. J. Cell Sci. 123:4011-4018. http://dx.doi.org/10.1242/jcs.078360
29. Nethe, M., E.C. Anthony, M. Fernandez-Borja, R. Dee, D. Geerts, P.J. Hensbergen, A.M. Deelder, G. Schmidt, and P.L. Hordijk. 2010. Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. J. Cell Sci. 123:1948-1958. http://dx.doi.org/10.1242/jcs.062919
30. Neve, R.M., K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F. Tong, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10:515-527. http://dx.doi.org/10.1016/j.ccr.2006.10.008
31. Omura, S., Y. Sasaki, Y. Iwai, and H. Takeshima. 1995. Staurosporine, a potentially important gift from a microorganism. J. Antibiot. 48:535-548. http://dx.doi.org/10.7164/antibiotics.48.535
32. Ory, S., H. Brazier, and A. Blangy. 2007. Identification of a bipartite focal adhesion localization signal in RhoU/Wrch-1, a Rho family GTPase that regulates cell adhesion and migration. Biol. Cell. 99:701-716. http://dx.doi.org/10.1042/BC20070058
33. Park, M.H., H.S. Lee, C.S. Lee, S.T. You, D.J. Kim, B.H. Park, M.J. Kang, W.D. Heo, E.Y. Shin, M.A. Schwartz, and E.G. Kim. 2013. p21-Activated kinase 4 promotes prostate cancer progression through CREB. Oncogene. 32:2475-2482. http://dx.doi.org/10.1038/onc.2012.255
34. Qu, J., X. Li, B.G. Novitch, Y. Zheng, M. Kohn, J.M. Xie, S. Kozinn, R. Bronson, A.A. Beg, and A. Minden. 2003. PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol. Cell. Biol. 23:7122-7133. http://dx.doi.org/10.1128/MCB.23.20.7122-7133.2003
35. Rafn, B., C.F. Nielsen, S.H. Andersen, P. Szyniarowski, E. Corcelle-Termeau, E. Valo, N. Fehrenbacher, C.J. Olsen, M. Daugaard, C. Egebjerg, et al. 2012. ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression. Mol. Cell. 45:764-776. http://dx.doi.org/10.1016/j.molcel.2012.01.029
36. Rantala, J.K., J. Pouwels, T. Pellinen, S. Veltel, P. Laasola, E. Mattila, C.S. Potter, T. Duffy, J.P. Sundberg, O. Kallioniemi, et al. 2011. SHA RPIN is an endogenous inhibitor of β1-integrin activation. Nat. Cell Biol. 13:1315-1324. http://dx.doi.org/10.1038/ncb2340
37. Rodriguez, M.S., J.M. Desterro, S. Lain, D.P. Lane, and R.T. Hay. 2000. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell. Biol. 20:8458-8467. http://dx.doi.org/10.1128/MCB.20.22.8458-8467.2000
38. Rolli-Derkinderen, M., V. Sauzeau, L. Boyer, E. Lemichez, C. Baron, D. Henrion, G. Loirand, and P. Pacaud. 2005. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ. Res. 96:1152-1160. http://dx.doi.org/10.1161/01.RES.0000170084.88780.ea
39. Saras, J., P. Wollberg, and P. Aspenström. 2004. Wrch1 is a GTPase-deficient Cdc42-like protein with unusual binding characteristics and cellular effects. Exp. Cell Res. 299:356-369. http://dx.doi.org/10.1016/j.yexcr.2004.05.029
40. Schiavone, D., S. Dewilde, F. Vallania, J. Turkson, F. Di Cunto, and V. Poli. 2009. The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways. Biochem. J. 421:283-292. http://dx.doi.org/10.1042/BJ20090061
41. Shepelev, M.V., and I.V. Korobko. 2012. Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV. Biochemistry Mosc. 77:26-32. http://dx.doi.org/10.1134/S0006297912010038
42. Shutes, A., A.C. Berzat, A.D. Cox, and C.J. Der. 2004. Atypical mechanism of regulation of the Wrch-1 Rho family small GTPase. Curr. Biol. 14:2052-2056. http://dx.doi.org/10.1016/j.cub.2004.11.011
43. Siu, M.K., H.Y. Chan, D.S. Kong, E.S. Wong, O.G. Wong, H.Y. Ngan, K.F. Tam, H. Zhang, Z. Li, Q.K. Chan, et al. 2010. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc. Natl. Acad. Sci. USA. 107:18622-18627. http://dx.doi.org/10.1073/pnas.0907481107
44. Tabusa, H., T. Brooks, and A.J. Massey. 2013. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling. Mol. Cancer Res. 11:109-121. http://dx.doi.org/10.1158/1541-7786.MCR-12-0466
45. Tao, W., D. Pennica, L. Xu, R.F. Kalejta, and A.J. Levine. 2001. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev. 15:1796-1807. http://dx.doi.org/10.1101/gad.894301
46. Teckchandani, A., G.S. Laszlo, S. Simó, K. Shah, C. Pilling, A.A. Strait, and J.A. Cooper. 2014. Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation. J. Cell Sci. 127:509-520. http://dx.doi.org/10.1242/jcs.127829
47. Tong, D., K. Czerwenka, J. Sedlak, C. Schneeberger, I. Schiebel, N. Concin, S. Leodolter, and R. Zeillinger. 1999. Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res. Treat. 56:91-97. http://dx.doi.org/10.1023/A:1006262501062
48. Vignal, E., M. De Toledo, F. Comunale, A. Ladopoulou, C. Gauthier-Rouvière, A. Blangy, and P. Fort. 2000. Characterization of TCL, a new GTPase of the rho family related to TC10 and Cdc42. J. Biol. Chem. 275:36457-36464. http://dx.doi.org/10.1074/jbc.M003487200
49. Visvikis, O., P. Lorès, L. Boyer, P. Chardin, E. Lemichez, and G. Gacon. 2008. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process. FEBS J. 275:386-396. http://dx.doi.org/10.1111/j.1742-4658.2007.06209.x
50. Wagner, S.A., P. Beli, B.T. Weinert, C. Schölz, C.D. Kelstrup, C. Young, M.L. Nielsen, J.V. Olsen, C. Brakebusch, and C. Choudhary. 2012. Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol. Cell. Proteomics. 11:1578-1585. http://dx.doi.org/10.1074/mcp.M112.017905
51. Wallace, S.W., J. Durgan, D. Jin, and A. Hall. 2010. Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B. Mol. Biol. Cell. 21:2996-3006. http://dx.doi.org/10.1091/mbc.E10-05-0429
52. Wang, G., Y. Gao, L. Li, G. Jin, Z. Cai, J.I. Chao, and H.K. Lin. 2012. K63-linked ubiquitination in kinase activation and cancer. Front Oncol. 2:5. http://dx.doi.org/10.3389/fonc.2012.00005
53. Wang, W., L. Lim, Y. Baskaran, E. Manser, and J. Song. 2013. NMR binding and crystal structure reveal that intrinsically-unstructured regulatory domain auto-inhibits PAK4 by a mechanism different from that of PAK1. Biochem. Biophys. Res. Commun. 438:169-174. http://dx.doi.org/10.1016/j.bbrc.2013.07.047
54. Wehrle-Haller, B. 2012. Structure and function of focal adhesions. Curr. Opin. Cell Biol. 24:116-124. http://dx.doi.org/10.1016/j.ceb.2011.11.001
55. Weissman, A.M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:169-178. http://dx.doi.org/10.1038/35056563
56. Wells, C.M., A. Abo, and A.J. Ridley. 2002. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J. Cell Sci. 115:3947-3956. http://dx.doi.org/10.1242/jcs.00080
57. Wells, C.M., A.D. Whale, M. Parsons, J.R. Masters, and G.E. Jones. 2010. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J. Cell Sci. 123:1663-1673. http://dx.doi.org/10.1242/jcs.055707
58. Whale, A.D., A. Dart, M. Holt, G.E. Jones, and C.M. Wells. 2013. PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity. Oncogene. 32:2114-2120. http://dx.doi.org/10.1038/onc.2012.233
59. Wilson, E., K. Leszczynska, N.S. Poulter, F. Edelmann, V.A. Salisbury, P.J. Noy, A. Bacon, J.Z. Rappoport, J.K. Heath, R. Bicknell, and V.L. Heath. 2014. RhoJ interacts with the GIT-PIX complex and regulates focal adhesion disassembly. J. Cell Sci. 127:3039-3051. http://dx.doi.org/10.1242/jcs.140434
60. Wu, X., and J.A. Frost. 2006. Multiple Rho proteins regulate the subcellular targeting of PAK5. Biochem. Biophys. Res. Commun. 351:328-335. http://dx.doi.org/10.1016/j.bbrc.2006.09.172
61. Yu, W., Y. Kanaan, Y.K. Bae, and E. Gabrielson. 2009. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet. Cytogenet. 193:29-37. http://dx.doi.org/10.1016/j.cancergencyto.2009.03.017
62. Zhang, H.J., M.K. Siu, M.C. Yeung, L.L. Jiang, V.C. Mak, H.Y. Ngan, O.G. Wong, H.Q. Zhang, and A.N. Cheung. 2011. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis. 32:765-771. http://dx.doi.org/10.1093/carcin/bgr033
63. Zhang, J., J. Wang, Q. Guo, Y. Wang, Y. Zhou, H. Peng, M. Cheng, D. Zhao, and F. Li. 2012. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. Cancer Lett. 317:24-32. http://dx.doi.org/10.1016/j.canlet.2011.11.007